Table 2.
Drug | Company | Indication | Phase | Status | ClinicalTrials.gov Identifier |
---|---|---|---|---|---|
Mavrilimumab | Kiniksa | RA | I | Completed | NCT00771420 |
RA | II | Completed | NCT01706926 | ||
RA | II | Completed | NCT01715896 | ||
RA | II | Terminated | NCT01712399 | ||
Giant cell arteritis | II | Active, not recruiting | NCT03827018 | ||
COVID-19 | II | Recruiting | NCT04399980 | ||
COVID-19 | II | Not yet recruiting | NCT04397497 |
Abbreviation: RA, rheumatoid arthritis.